Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. A Pan-European Prospective Multicenter Double Single Arm Cohort Study.

NCT06068023 is registered in ClinicalTrials.gov with Fondazione Poliambulanza Istituto Ospedaliero as lead sponsor.

NCT NCT06068023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06068023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. A Pan-European Prospective Multicenter Double Single Arm Cohort Study.
Lead sponsor
Fondazione Poliambulanza Istituto Ospedaliero
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2023
Completion date
July 1, 2029
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ampullary adenocarcinoma